Royal Bank Of Canada Marker Therapeutics, Inc. Transaction History

Royal Bank Of Canada

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.24 - $4.58 $48 - $925	202 Added 4040.0%	207 $0
Q3 2022 Nov 14, 2022	SELL	$0.3 - $3.73 $111 - $1,383	-371 Reduced 98.67%	5 $0
Q2 2022 Aug 15, 2022	BUY	$0.26 - $0.46 $97 - $172	376 New	376 $0
Q3 2021 Nov 15, 2021	SELL	$1.68 - $2.88 $2,565 - $4,397	-1,527 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$1.88 - $3.56 $2,870 - $5,436	1,527 New	1,527 $4,000

475K

Ticker MRKR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,599,200
Market Cap $163M
Description
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States. Its MultiTAA-specific T cell technology is based on the manufact...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.